Effect of silence S100A4 by RNA interference on proliferation,apoptosis,chemosensitivity of gemcitabine of the pancreatic cancer cell lines
Guo Fei
Abstract
Guo Fei
Abstract
OBJECTIVE: To observe the effect on the proliferation,apoptosis and chemosensitivity of gemcitabine after slience S100A4 by RNA interference.METHODS: the S100A4-specified small interference RNA was designed and synthesized.The expression of S100A4 was detected by RT-PCR 24 h after the S100A4 siRNA transfected into BxPC-3 and AsPC-1 cells.The growth curve of BxPC-3 and AsPC-1 cells were recorded to demonstrate the proliferation.The apoptosis of BxPC-3 and AsPC-1 cells was tested by flow cytometric analysis.The gemcitabine of IC50 was measured by MTT.RESULTS: S100A4 expression was suppressed significantly after S100A4 siRNA transfected into BxPC-3 and AsPC-1 cells.The abilities of proliferation were inhibited significantly after S100A4 siRNA transfected.TUNEL assay showed apoptosis increased after transfection.Before and after slience S100A4 by siRNA,IC50 of gemcitabine in control was(9.95±0.34) mmol/L,Negative Control was(9.641±0.434) mmol/L,Interference was(1.182±0.175) μmol/L,respectively;in AsPC-1,control was(64.15±3.41) mmol/L,Negative Control was(65.19±4.4) mmol/L,Interference was(1.962±0.113) mmol/L,respectively.CONCLUSIONS: S100A4 slience can inhibite cell proliferation and enhence the apoptosis as well as increase the chemosensitivity of gemcitabine.S100A4 could serve as a potential target in the filed of pancreatic cancer therapy.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To observe the effect on the proliferation,apoptosis and chemosensitivity of gemcitabine after slience S100A4 by RNA interference.METHODS: the S100A4-specified small interference RNA was designed and synthesized.The expression of S100A4 was detected by RT-PCR 24 h after the S100A4 siRNA transfected into BxPC-3 and AsPC-1 cells.The growth curve of BxPC-3 and AsPC-1 cells were recorded to demonstrate the proliferation.The apoptosis of BxPC-3 and AsPC-1 cells was tested by flow cytometric analysis.The gemcitabine of IC50 was measured by MTT.RESULTS: S100A4 expression was suppressed significantly after S100A4 siRNA transfected into BxPC-3 and AsPC-1 cells.The abilities of proliferation were inhibited significantly after S100A4 siRNA transfected.TUNEL assay showed apoptosis increased after transfection.Before and after slience S100A4 by siRNA,IC50 of gemcitabine in control was(9.95±0.34) mmol/L,Negative Control was(9.641±0.434) mmol/L,Interference was(1.182±0.175) μmol/L,respectively;in AsPC-1,control was(64.15±3.41) mmol/L,Negative Control was(65.19±4.4) mmol/L,Interference was(1.962±0.113) mmol/L,respectively.CONCLUSIONS: S100A4 slience can inhibite cell proliferation and enhence the apoptosis as well as increase the chemosensitivity of gemcitabine.S100A4 could serve as a potential target in the filed of pancreatic cancer therapy.
Key concepts: Gemcitabine, Apoptosis, Transfection, Pancreatic cancer, Small interfering RNA, Cell growth, MTT assay, RNA interference